EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Employing Late-Stage Functionalization Strategies to Address Metabolic Challenges in Drug Discovery

Kevin D. Dykstra, Amy B. McCracken, Melodie M. Christensen, Cheol K. Chung, Daniel DiRocco, George Doss, Kerry Fillgrove, David Hesk, Scott B. Hoyt, Claire Lankin, Derun Li, Guoqing Li, Yong Liu, Brian McKittrick, Mikhail Reibarkh, James Small, Eric Streckfuss, Brandon Taoka, Shawn Walsh, Li Xiao, Huifang Yao, Wendy Zhong, Shane W. Krska, Petr Vachal

Synlett · 2026-11-03

DOI: 10.1055/a-2981-3437 ↗
AbstractBibliografische Angaben

Abstract

Abstract In the course of medicinal chemistry campaigns, issues related to drug metabolism frequently present significant challenges to progressing chemical series toward tool molecules or clinical candidates. Addressing these issues typically requires designing molecules with specific point changes to test particular metabolism-related hypotheses. However, accessing these test molecules in a timely manner to inform future rounds of decision-making and design often presents a significant synthetic challenge. In this report, we present case studies showcasing the use of Minsici and direct metalation chemistries as part of a late-stage functionalization strategy to address specific metabolic issues plaguing two medicinal chemistry programs. The success of these approaches allowed rapid access to new analogs with improved metabolic stability, and more importantly, key insights that informed on strategies to progress these chemical series toward valuable tool compounds.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →